Company / Operating Income per Share
Amgen Operating Income per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
$16.91
FY2025
5-year range
$13.56 / $16.91
FY2021-FY2025
Trend
+24.8%
vs FY2024
Sector context
#4 of 201
Health Care
What the data says
Among 201 Health Care companies, Amgen is in the top 2% for operating income per share. Operating Income per Share returned to growth in FY2025 after 4 years of decline, reaching $16.91.
Based on SEC 10-K filings.
16.91 in FY2025 with a 5-year CAGR of -0.5%. Top quartile in the Health Care sector.
Improved from $14.79 to $16.91 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- +1.1%
- 5-Year CAGR
- -0.5%
- 10-Year CAGR
- -
Sector benchmark
Top 2% in Health CareTop 2% of 201This company $16.91 Sector average -$28.56
▼
+159.2% above sector average
Key checks
Key Insights
- In FY2025, operating income per share increased 24.8% year-over-year.
- Ranks #4 out of 201 companies in the Health Care sector.
- Peak operating income per share was recorded in FY2020.
- Lowest operating income per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 0.55 (distress zone, below 1.8 threshold)
- Strong return on equity: 72.8%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $16.91 | +24.8% |
| FY2024 | $13.56 | -8.3% |
| FY2023 | $14.79 | -9.7% |
| FY2022 | $16.37 | -2.1% |
| FY2021 | $16.73 | -3.6% |
| FY2020 | $17.35 | +9.6% |
| FY2019 | $15.84 | +16.8% |
| FY2018 | $13.56 | +18.2% |
| FY2017 | $11.47 | +39.7% |
| FY2016 | $8.21 | -26.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026